Abstract
Background
There is uncertainty about how directly observed treatment (DOT) support for tuberculosis (TB) can be delivered most effectively and how DOT support can simultaneously be used to strengthen human immunodeficiency virus (HIV) prevention and control among TB patients. This study describes how DOT support by community health workers (CHWs) was used in four municipalities in the Free State province – a high TB/HIV burden, poorly-resourced setting – to provide HIV outreach, referrals, and health education for TB patients.
Methods
The study was part of a larger cross-sectional study of HIV counselling and testing (HCT) among 1101 randomly-selected TB patients registered at 40 primary health care (PHC) facilities (clinics and community health centres) across small town/rural and large town/urban settings. Univariate analysis of percentages, chi-square tests and t-tests for difference in means were used to describe differences between the types of TB treatment support and patient characteristics, as well as the types of – and patient satisfaction with – HIV information and referrals received from various types of treatment supporters including home-based DOT supporters, clinic-based DOT supporters or support from family/friends/employers. Multivariate logistic regression was used to predict the likelihood of not having receiving home-based DOT and of never having received HIV counselling. The independent variables include poverty-related health and socio-economic risk factors for poor outcomes. Statistical significance is shown using a 95% confidence interval and a 0.05 p-value.
Results
Despite the fact that DOT support for all TB patients was the goal of South African health policy at the time (2012), most TB patients were not receiving formal DOT support. Only 155 (14.1%) were receiving home-based DOT, while 114 (10.4%) received clinic-based DOT. TB patients receiving home-based DOT reported higher rates of HIV counselling than other patients.
Conclusions
Public health providers should train DOT supporters to provide HIV prevention and target DOT to those at greatest risk of HIV, particularly those at greatest socio-economic risk.
Background
As highlighted in the Sustainable Development Goals (SDGs) [1], the world continues to face high rates of poverty and associated population health challenges, including the joint epidemics of tuberculosis (TB) and human immunodeficiency virus (HIV) [2]. High rates of TB-HIV co-infection necessitate HIV testing of all TB patients, yet, only 55% of notified TB patients in South Africa had a recorded HIV test result in 2015 [3]. With only about half of notified TB patients knowing their HIV status, the shortfalls and deficiencies in integration between TB and HIV services in the country become clear. Lack of progress in successfully integrating traditionally separate TB and HIV services into parallel programmes, staffing and approaches negates patients’ preference for combined services and results in wastage of scarce health resources and patients’ time and finances [4].
Both the link between TB and poverty [5–7] and the link between HIV and poverty [8–10] are well established. The Gini index for income inequality – an indicator for achieving SDG 10 to reduce inequality within and among countries – for South Africa was 63.4 in 2011 [11]. In the same year, 16.6% of the country’s population lived below the poverty headcount threshold of ZAR 13.81/US$ 1.90 (2011 exchange rate) per day [12]. The Free State is one of the poorest of the country’s nine provinces. Just more than 5% of the national public health-sector dependent population – of whom more than 80% are African and thus historically and socioeconomically disadvantaged – live in the Free State [3]. At ZAR 91994.00/US$ 12653.92 (2011 exchange rate), average annual household income in the province in 2010/2011 was substantially lower than that for the country as a whole at ZAR 119542.00/US$ 16443.19 (2011 exchange rate) [13]. In 2016, the Free State also had the lowest life expectancy for both males and females of all the provinces [14].
South Africa is extraordinarily challenged by the TB-HIV co-epidemic. The World Health Organization’s (WHO) global TB report shows that in 2016 the country had the highest total TB incidence rate in the world at 781 cases per 100,000 population compared to 140 cases per 100,000 population globally [15]. Further to the report, the HIV-positive TB mortality rate in South Africa was 181 per 100,000 population compared to five cases per 100,000 population globally and HIV prevalence in incident TB cases was 59% compared to 10% globally. In 2015, the Free State reported 15,833 cases of TB and that, in 2014, 70.3% of TB patients were HIV co-infected [3]. In 2014, the TB death rate in the province was substantially higher than that recorded for the country as a whole. A review of cases in the electronic TB register in the province from 2003 to 2012 revealed that both HIV co-infection and unknown HIV status were independently associated with increased likelihood of mortality while on TB treatment [16].
Directly observed support (DOT) continues to be commended as an efficacious approach to overcome interruption in both drug-susceptible TB (DS-TB) [17] and multidrug-resistant TB (MDR-TB) [18] treatment. Uncertainty however exists in the global and national guidelines about how and by whom DOT support for TB can be delivered most effectively and how DOT can simultaneously be used to strengthen uptake of HIV testing and treatment among TB patients. In 2017, the WHO conditionally recommended that the following treatment administration options may be offered to patients on DS-TB treatment: firstly, community- or home-based DOT was recommended over clinic-based DOT or unsupervised treatment; secondly, DOT administered by trained lay providers was recommended over DOT administered by family members or unsupervised treatment; and, thirdly, video observed treatment (VOT) could replace DOT where the technology was available [17].
The South African National Tuberculosis Management Guidelines released in 2014 state that the TB treatment supporter may be a healthcare worker, or a trained workplace or community health worker (CHW) or whoever patients choose to watch them swallowing the tablets “in a way that is sensitive and supportive to the patient’s needs” [19 p. 56]. Further to the guidelines, DOT services must be organised to suit the patients’ circumstances and must be provided as close to their homes as possible, unless patients live close to a clinic and it is convenient for them to take their treatment at the clinic. The guidelines prioritise the following groups for treatment support: children, elderly or infirm patients; those with a history of interrupting treatment, substance or alcohol abuse or mental illness; those who request a treatment supporter; and those who are homeless or living under poor social conditions. There is however considerable variation in how DOT is implemented, how HIV-related services have been integrated into DOT support, and the extent of cross-training to deliver both programmes’ services in South Africa.
Due to the wide use of an intensive service (directly observing patients taking their pills on a daily basis), DOT has been extensively studied for its impact on retention in treatment and treatment outcomes. Results have been mixed, and controversy remains about whether DOT is effective. Individual studies have shown that integrating DOT with an HIV home care programme improved outcomes for TB patients in Zambia [19]. A study in the Western Cape province of South Africa found community-based DOT to be more cost-effective than clinic-based DOT [20]. A study in Namibia showed that TB patients on the community-based TB treatment option had better cure rates than those on clinic-based DOT or self-administered TB treatment [21]. Another South African study in the Northern Cape province found the effects of DOT to be concentrated among patients undergoing retreatment for TB [22]. Qualitative studies in Ethiopia [23] and Pakistan [24] showed some of the potential advantages for clinics and patients with community-based DOT such as patients not having to travel to a clinic for DOT and alleviation of clinic-based healthcare workers’ time constraints by engaging CHWs.
However, a Cochrane review of 11 clinical trials concluded that TB cure and treatment completion rates were not improved by DOT [25]. A similar conclusion was drawn from a meta-analysis of ten studies (including five trials) which found that DOT was not significantly better than self-administered treatment in preventing microbiologic failure, relapse or adverse drug reactions [26]. Thereupon, a systematic review and meta-analysis of eight studies (including one trial) that compared the effectiveness of community-based versus clinic-based DOT concluded that community-based DOT had higher treatment success, but conceded that the evidence for this was not strong [27]. A systematic review of ten trials and eight quasi-experimental studies found evidence of beneficial effects from DOT with regard to treatment adherence and in terms of cure and treatment success rates, but no beneficial effect in terms of increasing the treatment completion rate [28]. Another systematic review of 23 studies (eight trials) concluded that while there was no convincing evidence that clinic-based DOT was more effective than self-administered treatment, there was convincing evidence that community-based DOT was more effective than self-administered DOT and that community-based DOT was as or more effective than clinic-based DOT [29]. This was corroborated by another systematic review and meta-analysis of eight trials and nine cohort studies finding that community-based DOT did improve TB treatment outcomes [30].
A systematic review and meta-analysis of 31 studies in 22 countries focusing specifically on MDR-TB patients showed that providing DOT for a full course of treatment was associated with a significantly higher treatment success rate [31]. However, this study reported no significant differences in the treatment success rates for DOT variously provided to MDR-TB patients by healthcare providers, family members and private DOT providers or between patients having clinic-based DOT and home-based DOT. Perhaps the most compelling argument in favour of maintaining DOT for both DS-TB and MDR-TB is that no large-scale TB programme without DOT has achieved the global TB targets, while most programmes using DOT achieve or nearly achieve these targets [32]. Nevertheless, it is argued that the effectiveness of DOT still needs to be more rigorously evaluated through a pragmatic experimental trial conducted in real-world programme settings [33].
Research in the Free State province showed relative patient satisfaction with HIV counselling provided to TB patients by both lay counsellors and nurses and recommended that expanded use of lay counsellors in TB/HIV programmes could help mitigate the human resource crisis that had resulted primarily from shortages of nurses [34]. However, despite undergoing a standard 59-day training programme, knowledge deficits among DOT supporters concerning TB, HIV and the link between TB and HIV have been identified [35–37]. Stigmatisation against people living with HIV/AIDS (PLWHA) has also been observed in a survey of CHWs (over half of whom were DOT supporters) in the province observing that about 15% of respondents agreed with the statement “Most people with HIV/AIDS only have themselves to blame” [38].
This study describes how DOT support by CHWs was used in one province of South Africa, the Free State, to provide HIV outreach, referrals, and education for TB patients in 2012. The study addressed the following specific research questions: 1) what type of support did patients receive for their TB treatment (home-based DOT, clinic-based DOT, or support by family/friends/employer?; 2) what were the characteristics of the TB patients who did and did not receive DOT support – in particular, did the most vulnerable patients receive support?; 3) what type of HIV-related services – in particular referrals to HCT – did patients receive from their supporters?; 4) how satisfied were patients with the HIV-related information they received, and how did that vary by type of supporter?; and 5) what effect did DOT support – in particular home-based DOT support – have on receipt of HCT?
Methods
Setting and design
The study was part of the cross-sectional baseline study of a larger intervention project to improve uptake of HCT among TB patients in the Free State. A patient survey was conducted in four local municipalities or sub-districts – Matjhabeng, Maluti-a-Phofung, Setsoto and Dihlabeng – in March to April, 2012. These municipalities were chosen purposively, because they are among the most economically deprived in South Africa [39] and because they represent a combination of small town/rural (Setsoto and Dihlabeng) and large town/urban (Matjhabeng and Maluti-a-Phofung) settings. Table 1 shows socio-economic characteristics of the four municipalities in 2011. The study was limited to TB patients who received treatment in primary health care (PHC) facilities (clinics and community health centres), which is the primary source of health care for a majority of South Africans, historically-disadvantaged persons in particular [40]. The research was authorised by the Free State Department of Health, and the Institutional Review Board of the University of the Free State approved the research protocol.
Table 1.
Characteristics of study areas
| Municipality | % Having characteristic | |||
|---|---|---|---|---|
| Unemployed | Households agricultural | With no schooling | Without piped water inside dwelling | |
| Dihlabeng | 28.7% | 28.7% | 8.9% | 56.28% |
| Maluti-a-Phofung | 41.8% | 51.6% | 8.9% | 68.1% |
| Matjhabeng | 37.0% | 13.6% | 4.6% | 45.2% |
| Setsoto | 35.7% | 29.1% | 8.7% | 68.6% |
Sampling and data collection
The estimated sample size – to attain a 15 percentage point effect in uptake of HCT by TB patients with 80% power and two-tailed test significance of P < 0.05 – at the end of the intervention period of the overall study – was 295 per municipality, that is 1 180 in total [38]. Within each municipality, ten clinics that served at least ten TB patients a year were randomly selected. Within clinics, a random sample (proportionate to the total clinic patient headcount) of registered TB patients over age 18 was selected to be interviewed. A TB nurse at the clinic informed the sampled patients about the study, obtained their informed consent to participate, and scheduled an appointment for them to come to the clinic for the interview. Patients were compensated ZAR 15.00/US$ 1.82 (2012 exchange rate) for transport to the clinic. Resource constraints did not allow for inflation of the sample size to compensate for respondent attrition, refusal to participate, or non-response to certain question items. The final sample size was 1 101 – 6.7% of the original sample could not be accommodated due to patients not coming to the clinic for their scheduled interview. This was usually because they had either completed treatment or died.
Conducted in either English or Sesotho according to the patient’s preference, the fieldworker-administrated questionnaire schedule took about 45 min to complete. Six questions collected socio-demographic and socio-economic information: 1) sex (male/female); 2) age (continuous); 3) marital/cohabiting status (married/living with a sexual partner or not married/living with a sexual partner); 4) highest formal educational qualification (no/primary school or secondary school/higher); 5) employment status (employed/unemployed); and 6) housing quality (main walling material, kind of toilet facility, and availability of tap drinking water and electricity).
Seven questions inquired about DOT support: 1) who supported the patient while on TB treatment (home-based DOT, clinic-based DOT, support from family/friends/employer, or no one); 2) whether the supporter provided the patient with information on the relationship between TB and HIV/AIDS (yes/no); 3) whether the supporter encouraged the patient to undergo HIV counselling (yes/no); 4) whether the patient ever received HIV counselling (yes/no); 5) whether the supporter was influential in the patient’s decision to undergo HIV counselling (yes/no); 6) how long after the TB diagnosis the patient underwent HIV testing (days); and 7) how the patient rated the DOT supporter in terms of clarity of information about the link between TB and HIV, opportunity to ask questions, thoroughly discussing information about TB and HIV and the benefits of getting tested for HIV, and language used (scale ranging from 1 to 5, where 1 was “very dissatisfied” and 5 was “very satisfied”). Additionally, one question collected clinical information: whether the current episode was the first time the patient had TB (yes/no).
While patients were asked whether they had ever had an HIV test, that response is not part of this analysis. This is because only ten of the 1 101 TB patients reported never having had an HIV test. At the time of the study, it was the protocol for all public health providers to encourage TB patients to have an HIV test and to record the result in the TB register. Results (testing rates) were used as an indicator of health district performance.
Data analysis
Data were processed and analysed using IBM SPSS statistics for windows, version 24. The significance of difference in proportions was tested using chi-square and t-tests. The multivariate analysis used logistic regression. Regression results are presented as odds ratios with corresponding confidence intervals and p-values for statistical significance. The independent variables included in the regression models were poverty-related health and socio-economic risk factors for poor outcomes, including socio-demographic characteristics (gender and age); socio-economic characteristics (marital status, employment status, and housing quality); and clinical status (retreatment for TB). Outcome variables included the following: type of support, type of HIV services received from the supporter, whether the patient received HIV counselling, whether the supporter influenced the patient’s decision to undergo HIV counselling, whether the HIV test took place within one week after referral, whether the supporter influenced the patient’s decision to undergo HIV testing, and the patient’s satisfaction with the supporter’s services.
Results
Type of DOT support received
The type of DOT support patients reported receiving is indicated separately by municipality in Table 2.
Table 2.
Type of support for TB treatment by municipality
| Municipality | Number (row %) | Total | |||
|---|---|---|---|---|---|
| Home-based DOT | Clinic-based DOT | Family/friend/employer support | No one | ||
| Dihlabeng | 25 (9.8) | 20 (7.9) | 76 (29.9) | 133 (52.4) | 254 (100.0) |
| Maluti-a-Phofung | 58 (22.3) | 27 (10.4) | 141 (54.2) | 34 (13.1) | 260 (100.0) |
| Matjhabeng | 30 (10.2) | 21 (7.1) | 134 (45.4) | 110 (37.3) | 295 (100.0) |
| Setsoto | 42 (14.4) | 46 (15.8) | 172 (58.9) | 32 (11.0) | 292 (100.0) |
| Total | 155 (14.1) | 114 (10.4) | 523 (47.5) | 309 (28.0) | 1101 (100.0) |
Note 1: Chi-square test for differences in proportions of type of support across municipalities is significant at P < 0.001
Note 2: Type of support measured by responses to the question: “Who is supporting you while you are on TB treatment?”
Overall, only 14.1% of patients had DOT support at home, while an additional 10.4% reported DOT support at a clinic. There were significant differences by municipality, with rates ranging from 22.3% home-based DOT in Maluti-a-Phofung to only 9.8% in Dihlabeng. There was also a substantial range for those reporting clinic-based DOT (from 7.1% in Matjhabeng to 15.8% in Setsoto). Almost half of the patients (47.5%) reported support from family/friends/employers with a range from 29.9% (Dihlabeng) to 58.9% (Setsoto). The remainder of the patients stated that they had no support for their TB treatment, fully 52.4% in Dihlabeng.
Characteristics of patients who received/did not receive DOT support
Table 3 shows several need-related patient characteristics according to the type of support they received while on treatment. Half (50.2%) of patients were male, with no significant gender difference by support type. However, those with DOT support at home were significantly older (mean age 42.0 years) than those supported by family/friends/employers (mean age 38.0 years) and those having no support (mean age 38.3 years).
Table 3.
Characteristics of TB patients on treatment by type of treatment support received
| Characteristic | Number (%) having each characteristic by type of support | Total patients | Significant difference in characteristic by type of support | |||
|---|---|---|---|---|---|---|
| Home-based DOT | Clinic-based DOT | Family/friend/employer support | No one | |||
| Total N | 155 | 114 | 523 | 309 | 1101 | – |
| Male (%) | 72 (46.5) | 69 (60.5) | 265 (50.7) | 147 (47.6) | 553 (50.2) | NS |
| Mean age (SD) | 42.0 (14.3) | 40.0 (11.1) | 38.0 (12.7) | 38.3 (14.3) | 38.8 (12.6) | ** (Note 2) |
| Unemployed (%) | 125 (80.6) | 85 (74.6) | 388 (74.2) | 225 (72.8) | 823 (74.7) | NS |
| Unmarried and not cohabiting (%) | 75 (48.4) | 62 (54.4) | 290 (55.4) | 191 (61.8) | 618 (56.1) | * |
| Very poor housing (%) | 22 (14.2) | 34 (29.8) | 136 (26.0) | 62 (20.1) | 254 (23.1) | ** |
| No or only primary education (%) | 51 (35.5) | 41 (36.0) | 141 (27.0) | 93 (31.1) | 326 (29.6) | NS |
| Undergoing retreatment for TB (%) | 25 (16.1) | 32 (28.0) | 101 (19.3) | 66 (21.3) | 224 (20.3) | NS |
Note 1: *P < 0.05; **P < 0.01; NS = Not significant; Chi-square test for differences in proportions. T-test for difference in means
Note 2: Mean age for DOT at home is significantly different from Family/friends and No one, P < 0.01. Other age differences are non-significant
Note 3: Type of support measured by responses to the question: “Who is supporting you while you are on TB treatment?”
Overall, a very large proportion (74.7%) of TB patients were unemployed, but there was no significant difference across their type of support. Among those receiving home-based DOT support, 48.4% were without a partner or spouse at home, compared to 61.8% among those without any support. While it would seem that those without a spouse or partner would be in greater need of support, they were more often without any. About a quarter (23.1%) of TB patients in the sample lived in poor quality housing. These individuals, potentially the highest need group, also were significantly less likely to have DOT support at home. There was no significant difference in level of education by type of support, with between 27.1% and 36.6% of patients having primary school or no education, regardless of their type of support. Finally, national guidelines suggest that those undergoing retreatment for TB should be targeted for DOT support to prevent relapse, but that was not the case. About a fifth (20.3%) reported undergoing retreatment for TB, with no significant difference in that percentage across type of support.
The results from a multivariate logistic regression analysis predicting not having DOT support at home are shown in Table 4. Odds ratios are shown for each of the risk characteristics. The multivariate analysis confirmed the results reported above. Older patients were significantly less likely to have no support compared with their younger counterparts, while those who were without a partner and those in poor quality housing were more likely to have no DOT support at home. While the odds ratios for males, those with only primary or no school education, and those undergoing retreatment for TB were all positive (suggesting they may have also have been more likely to have no home-based DOT support), these odds ratios are not statistically significant. Still, given that these are risk factors that would suggest they should have been targeted for home-based DOT support (especially those undergoing retreatment for TB), it is clear they were not.
Table 4.
Logistic regression predicting likelihood of not having DOT at home
| Control variable | Odds ratio | Confidence interval | Significance |
|---|---|---|---|
| Sex | |||
| Female | 1.00 | – | NS |
| Male | 1.28 | (0.89,1.83) | |
| Age (continuous) | 0.98 | (0.96, 0.99) | ** |
| Employment | |||
| Employed | 1.00 | – | NS |
| Unemployed | 0.65 | (0.42, 1.01) | |
| Marital status | |||
| Married or cohabiting | 1.00 | – | * |
| Unmarried and not cohabiting | 1.47 | (1.02, 2.11) | |
| Housing quality | |||
| Not in very poor housing | 1.00 | – | ** |
| In very poor housing | 1.84 | (1.13, 2.99) | |
| Education | |||
| Secondary school or higher | 1.00 | – | NS |
| No or only primary school | 1.15 | (0.74, 1.79) | |
| Undergoing retreatment for TB | |||
| No | 1.00 | – | NS |
| Yes | 1.42 | (0.90, 2.27) | |
Note 1: *P < 0.05; *P < 0.01; NS = Not significant
Note 2: Includes all patients in the sample, N = 1101
Note 3: Computed using SPSS procedure Binary Logistic
HIV-related services
Surveyed patients were asked what type of HIV-related services they received from their supporter, both formal DOT supporters and other supporters. These results are shown in Table 5. The percentage of patients with some HIV services from their supporter was high, about two-thirds or more of patients depending on the service and type of support. For example, over 60% of all three groups reported that their supporter influenced their decision to have HIV counselling. The pattern is clear that DOT supporters (either at home or at a clinic) provided significantly more HIV-related services than those being supported by family/friends/employers. With one exception (having an HIV test within one week of TB diagnosis), all the differences in the six HIV-service related responses were statistically significant, and in all cases those with DOT support at home had the largest percentage answering “yes.”
Table 5.
Types of HIV information and referral received from DOT supporter and patient satisfaction by type of DOT supporter
| Outcome | Home-based DOT | Clinic-based DOT | Family/friend/employer support | Significance |
|---|---|---|---|---|
| Number (%) answering yes | ||||
| Total N | 155 | 114 | 523 | |
| Information on HIV-TB link from supporter | 112 (83.2) | 95 (83.3) | 435 (72.3) | ** |
| Encouragement for HIV counselling | 117 (75.4) | 78 (68.4) | 323 (61.8) | ** |
| Receipt of HIV counselling | 147 (94.8) | 106 (93.0) | 459 (87.8) | * |
| Supporter influenced HIV counselling | 117 (75.4) | 78 (68.4) | 322 (61.6) | ** |
| HIV test within week of referral | 285 (86.0) | 72 (88.9) | 92 (83.3) | NS |
| Supporter influenced HIV testing | 117 (75.5) | 78 (68.4) | 323 (61.8) | ** |
| Satisfaction with supporter for: | Mean | |||
| - Clarity of info about HIV and TB | 4.57 | 4.40 | 4.42 | NS |
| - Opportunity to ask questions | 4.60 | 4.29 | 4.39 | NS |
| - Info on HIV and TB was thorough | 4.60 | 4.51 | 4.47 | NS |
| - Info about the benefit of HIV testing | 4.52 | 4.46 | 4.47 | NS |
| - Language used | 4.71 | 4.72 | 4.67 | NS |
Note 1: *P < 0.05; ** P < 0.01; NS = Not significant. T-test for difference in means
Note 2: Among those reporting any support for treatment, N = 792
Note 3: Patients rated their satisfaction on a Likert scale ranging from 1 to 5, where 1 was “very dissatisfied” and 5 was “very satisfied”
Patient satisfaction with DOT supporter HIV-related services
Patients were asked five questions about their satisfaction with the HIV information and referrals received from their supporter. The pattern concerning satisfaction with the services received is not as clear as with receipt of services, in terms of differences between those receiving home-based or clinic-based DOT or receiving support from others. Indeed, there were no statistically significant differences between the groups in any of the satisfaction measures. For example, patients receiving DOT support at home rated their satisfaction with opportunity to ask questions at a mean of 4.6 on a Likert scale ranging from 1 to 5, where 1 was “very dissatisfied” and 5 was “very satisfied.” Patients receiving DOT support at a clinic and those supported by others rated their satisfaction at a mean of 4.3 and 4.4 respectively. These apparent differences were not statistically significant. In terms of satisfaction with the clarity and thoroughness of information on HIV and TB received, information about the benefits of HIV testing, and language used the responses were almost identical across the groups.
Effect of DOT at home on receipt of HIV counselling
Table 6 shows the results from a logistic regression analysis of the likelihood of not receiving HIV counselling, controlling for demographic risk factors and by whether the patient received DOT support at home. Those without DOT support at home were almost three times as likely to not have received HIV counselling as other TB patients. Other risk factors for not receiving HIV counselling were not significant, except for age. In this case, older age was a risk factor after controlling for DOT support at home and other risk factors.
Table 6.
Logistic regression predicting likelihood of never having received HIV counselling
| Control variable | Odds ratio | Confidence interval | Significance |
|---|---|---|---|
| DOT support | |||
| Home-based DOT support | 1.00 | – | |
| No home-based DOT support | 2.87 | (1.36, 6.06) | ** |
| Sex | |||
| Female | 1.00 | – | |
| Male | 1.01 | (0.69, 1.49) | NS |
| Age (continuous) | 1.02 | (1.01, 1.04) | ** |
| Employment | |||
| Employed | 1.00 | – | |
| Unemployed | 0.80 | (0.53, 1.22) | NS |
| Marital status | |||
| Married or cohabiting | 1.00 | – | |
| Unmarried and not cohabiting | 0.87 | (0.59, 1.28) | NS |
| Housing quality | |||
| Not in very poor housing | 1.00 | – | |
| In very poor housing | 0.97 | (0.62, 1.54) | NS |
| Education | |||
| Secondary school or higher | 1.00 | – | |
| No or only primary school | 0.86 | (0.54, 1.39) | NS |
| Undergoing retreatment for TB | |||
| No | 1.00 | – | |
| Yes | 1.06 | (0.67, 1.67) | NS |
Note 1: **P < 0.01; NS = Not significant
Note 2: Includes all patients in the sample, N = 1101
Note 3: Computed using SPSS procedure Binary Logistic
Discussion
The WHO End TB Strategy envisions a TB-free world. The first of the three pillars of the strategy is “integrated, patient-centred care and prevention”; the second is “bold policies and supportive systems”; and the third is “intensified research and innovation” ([41] p.2). “Social protection, poverty alleviation and actions on other determinants of TB” is a component of the second pillar ([41] p.2). One of the ways to do this is by providing effective community-based DOT and HIV services to TB patients at greatest socio-economic risk.
Guidelines for HIV providers in South Africa at the time of the survey (2012) suggested that lay counsellors should play a role in supporting patients [42]. For TB patients, lay counsellors were generally DOT supporters, many of whom had been cross-trained to provide HIV services. While much, but not all, prior research suggests that DOT can be effective for improving TB [22, 28–30] and MDR-TB [31] patient outcomes, research on the effect of DOT specifically on receipt of HIV services is limited. Our research from four municipalities in the Free State province suggests that DOT support – when it was received - facilitated access to a range of HIV counselling services. For example, DOT supporters were encouraging TB patients to take up HCT and educating them about the relationship between TB and HIV. However, at the time of the study the large majority of TB patients in these municipalities were not receiving any formal DOT support. Only 14.1% were receiving home-based DOT, while another 10.4% were receiving clinic-based DOT. This is in spite of the fact that DOT support for all TB patients was the goal of South African health policy at the time.
Prior research [43] and South African guidelines [44] emphasise that DOT support should especially be targeted to the most vulnerable patients. We examined specifically the effect of home-based DOT support and whether it was being targeted to the most vulnerable TB patients. With the exception of older patients being more likely to receive DOT at home, other vulnerable groups were not apparently targeted. Indeed, those in the poorest quality housing were less likely to have home-based DOT support than other TB patients. This finding is similar to that of a recent study in India showing that the most vulnerable TB patients faced the most difficulties in accessing DOT and completing treatment [45].
The advantage of age in receipt of home-based DOT did however not translate into higher rates of receipt of HIV counselling for older patients. It could be that DOT supporters were unassuming or demure about providing HIV-related advice to an older person or may have thought that an older person was unlikely to be in need of HIV counselling, especially when they were a friend or family member.
The study provides important information that is relevant to development of new policies concerning use of CHWs in addressing the TB/HIV co-epidemic. In particular, if cross-training in HIV services can become a standard part of DOT training, CHWs who have frequent contact with TB patients could become an important cadre of front-line HIV prevention personnel in non-clinical community-based settings. Further, in choosing who might receive DOT, it is critical that such a programme target those at the highest socio-economic and clinical risk.
The study is limited to four municipalities in Free State, South Africa at one point in time. In addition, data are self-reported. This particularly may affect how TB patients reports their DOT support. While the term “DOT supporter” implies Directly Observed Treatment, it is possible that the support that patients reported was not necessarily someone observing them taking medication regularly, but was rather someone they saw more occasionally who provided counselling and support. The data do not indicate some important aspects of the HIV services that the DOT supporters, or other supporters, were providing. For example, it is likely that some supporters provided HIV counselling (a direct service), and others encouraged patients to receive counselling at a clinic (a referral). The data do not distinguish these service differences. Another limitation of this analysis is that we did not compare patient treatment outcomes (for example mortality) between patients on DOT and those who were not, since all patients were alive and on treatment at the time of data collection.
Conclusion
Recent policy developments in South Africa provide some opportunities to improve services for TB patients, through a new “PHC re-engineering strategy,” which includes the deployment of facility-linked outreach and family health teams [46]. Currently, the scope of work of the CHWs serving on these teams, other than in exceptional cases, does not include DOT support. In addition, the teams do not visit households on a daily basis. It is not clear to what extent workers will be cross-trained in both TB and HIV prevention and treatment. Consequently, some of the benefits that co-infected patients might receive from dedicated daily DOT support may no longer be available. It will be important for the national and provincial governments to assure that the benefits of DOT for HIV counselling and prevention – as documented in this study – are not lost with the implementation of the new PHC strategy.
Acknowledgments
The authors thank the Free State Department of Health for approving and supporting the research.
Funding
Financial support was received from National Research Foundation, Centers for Disease Control – South Africa, and American International Health Alliance HIV/AIDS Twinning Center. Opinions expressed and conclusions reached are those of the authors and do not necessarily reflect the views of the funders.
Availability of data and materials
The dataset analysed during the current study is available from the corresponding author on reasonable request.
Abbreviations
- CCG
Community caregiver
- CHW
Community health worker
- DOT
Directly observed treatment
- DS-TB
Drug-susceptible TB
- HCT
HIV counselling and testing
- HIV
Human immunodeficiency virus
- MDR-TB
Multidrug-resistant tuberculosis
- PHC
Primary Health Care
- SDG
Sustainable development goal
- TB
Tuberculosis
- VOT
Video observed treatment
- WHO
World Health Organization
Authors’ contributions
EMH analysed data and drafted the manuscript. NGK and JCH conducted literature study, instrument development, managed data gathering and participated in data analysis and write-up. All authors contributed to review the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the Faculty of Health Sciences, University of the Free State. Informed, written consent was obtained from participating TB patients.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Embry M. Howell, Email: ehowell@urban.org
N. Gladys Kigozi, Email: kigozign@ufs.ac.za.
J. Christo Heunis, Email: heunisj@ufs.ac.za.
References
- 1.United Nations. Sustainable Development Goals. http://www.un.org/sustainabledevelopment/sustainable-development-goals/. 2015. Accessed 3 Jan 2017.
- 2.Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375:1814–1829. doi: 10.1016/S0140-6736(10)60483-7. [DOI] [PubMed] [Google Scholar]
- 3.Day C, Gray A. Health and related indicators. In: Padarath A, Barron P, editors. South African Health Review 2017. Durban: Health Systems Trust; 2017. p. 217–339.
- 4.Heunis JC, Wouters E, Kigozi NG. HIV, AIDS and tuberculosis in South Africa: trends, challenges and responses. In: Van Rensburg HCJ, editor. Health and health care in South Africa. 2. Pretoria: Van Schaik Publishers; 2012. pp. 293–360. [Google Scholar]
- 5.Das P, Horton R. Tuberculosis – getting to zero. Lancet. 2015;386:2231–2232. doi: 10.1016/S0140-6736(15)00401-8. [DOI] [PubMed] [Google Scholar]
- 6.Ortblad K, Salomon J, Barnighausen T, Atun F. Stopping tuberculosis: a biosocial model for sustainable development. Lancet. 2015;386:2354–2362. doi: 10.1016/S0140-6736(15)00324-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Harling G, Ehrlich R, Myer L. The social epidemiology of tuberculosis in South Africa: a multilevel analysis. Soc Sci Med. 2008;66:492–505. doi: 10.1016/j.socscimed.2007.08.026. [DOI] [PubMed] [Google Scholar]
- 8.Kalichman SC, Kalichman MO. HIV-related stress and life chaos mediate the association between poverty and medication adherence among people living with HIV/AIDS. J Clin Psychol Med Settings. 2016;23(4):420–430. doi: 10.1007/s10880-016-9481-8. [DOI] [PubMed] [Google Scholar]
- 9.Magadi MA. Understanding the urban-rural disparity in HIV and poverty nexus: the case of Kenya. J Public Health (Oxf) 2017;39(3):e63–e72. doi: 10.1093/pubmed/fdw065. [DOI] [PubMed] [Google Scholar]
- 10.Nattrass N, Maughan-Brown B, Seekings J, Whiteside A. Poverty, sexual behaviour, gender and HIV infection among young black men and women in Cape Town, South Africa. Afr J AIDS Res. 2012;11(4):307–17. [DOI] [PubMed]
- 11.World Bank Open Data. Gini index. Washington, D.C., USA. https://data.worldbank.org/indicator/SI.POV.GINI. 2017. Accessed 13 Dec 2017.
- 12.World Bank Open Data. Poverty headcount ratio at $1.90 a day. Washington, D.C., USA. https://data.worldbank.org/indicator/SI.POV.DDAY?view=chart. 2017. Accessed 13 Dec 2017.
- 13.Statistics South Africa . Income and expenditure of households, 2010/2011. Statistical release P0100. Pretoria: Statistics South Africa; 2012. [Google Scholar]
- 14.Statistics South Africa. Mid-year population estimates 2017. http://www.statssa.gov.za/publications/P0302/P03022017.pdf. 2017. Accessed 13 Dec 2017.
- 15.World Health Organization. The Global Tuberculosis Report 2017. Geneva, Switzerland: WHO; 2017.
- 16.Heunis JC, Kigozi NG, Chikobvu P, Botha S, van Rensburg HCJD. Risk factors for mortality during TB treatment: a 10-year electronic record review in a South African province. BMC Public Health. 2017;17:38. doi: 10.1186/s12889-016-3972-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. WHO/HTM/TB/2017.05. 2017. Accessed 11 Dec 2017.
- 18.Department of Health, Republic of South Africa. Management of drug-resistant tuberculosis. Policy Guidelines (Updated – January 2013). https://www.health-e.org.za/wp-content/uploads/2014/06/MDR-TB-Clinical-Guidelines-Updated-Jan-2013.pdf. 2013. Accessed 17 Dec 2017.
- 19.Miti S, Mfungwe V, Reijer P, Maher D. Integration of tuberculosis treatment in a community-based home care programme for persons living with HIV/AIDS. Int J Tuberc Lung Dis. 2003;7(9):S92–S98. [PubMed] [Google Scholar]
- 20.Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis. 2003;11(9):S56–S62. [PubMed] [Google Scholar]
- 21.Zvavamwe Z, Ehlers VJ. Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study. Int J Nurs Stud. 2009;46(3):302–309. doi: 10.1016/j.ijnurstu.2008.09.013. [DOI] [PubMed] [Google Scholar]
- 22.Kironde S, Meintjies M. Tuberculosis treatment delivery in high burden settings: does patient choice of supervision matter. Int J Tuberc Lung Dis. 2002;6(7):599–608. [PubMed] [Google Scholar]
- 23.Fiseha D, Demissie M. Assessment of directly observed therapy (DOT) following tuberculosis regimen change in Addis Ababa, Ethiopia: a qualitative study. BMC Infect Dis. 2015;15:405. doi: 10.1186/s12879-015-1142-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Khan MA, Walley JD, Witter SN, Shah SK, Javeed S. Tuberculosis patient adherence to direct observation; results of a social study in Pakistan. Health Policy Plan. 2005;20(6):354–365. doi: 10.1093/heapol/czi047. [DOI] [PubMed] [Google Scholar]
- 25.Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2015;5:CD003343. [DOI] [PMC free article] [PubMed]
- 26.Pasipanodya JG, Gumbo T. A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis. 2013;57:21–31. doi: 10.1093/cid/cit167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wright CM, Westerkamp L, Korver S, Dobler CC. Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2015;5:210. doi: 10.1186/s12879-015-0945-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Suwankeeree W, Picheansathian W. Strategies to promote adherence to treatment by pulmonary tuberculosis patients: a systematic review. Int J Evid Based Healthc. 2014;12(1):3–16. doi: 10.1097/01.XEB.0000444614.17658.46. [DOI] [PubMed] [Google Scholar]
- 29.Tian JH, Lu ZX, Bachmann MO, Song F-J. Effectiveness of directly observed treatment of tuberculosis: a systematic review of controlled studies. Int J Tuberc Lung Dis. 2014;18(9):1092–1098. doi: 10.5588/ijtld.13.0867. [DOI] [PubMed] [Google Scholar]
- 30.Zhang H, Ehiri J, Yang H, Tang S, Li Y. Impact of community-based DOT on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS One. 2016;11(2):e0147744. [DOI] [PMC free article] [PubMed]
- 31.Yin J, Yuan J, Hu Y, Wei X. Association between directly observed therapy and treatment outcomes in multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150511. doi: 10.1371/journal.pone.0150511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Frieden TR, Sbabaro JA. Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull World Health Organ. 2007;85(5):407–409. doi: 10.2471/BLT.06.038927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.McLaren ZM, Milliken AA, Meyer AJ, Sharp AR. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy. BMC Infect Dis. 2016;16:537. doi: 10.1186/s12879-016-1862-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kigozi NG, Heunis JC, van den Berg HS. Tuberculosis patients’ perspectives on HIV counselling by lay counsellors vis-à-vis nurses: an exploratory study in two districts of the Free State Province, South Africa. Afr J Nurs Midwifery. 2011;13(1):71–80. [Google Scholar]
- 35.Heunis JC, Wouters E, Norton WE, Engelbrecht MC, Kigozi NG, Sharma A, et al. Patient- and delivery-level factors related to acceptance of HIV counseling and testing services among tuberculosis patients in South Africa: a qualitative study with community health workers and program managers. Implement Sci. 2011;6:27. doi: 10.1186/1748-5908-6-27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Heunis C, Wouters E, Kigozi G, Janse van Rensburg-Bonthuyzen E, Jacobs N. TB/HIV-related training, knowledge and attitudes of community health workers in the Free State province, South Africa. Afr J AIDS Res. 2013;12(2):113–119. doi: 10.2989/16085906.2013.855641. [DOI] [PubMed] [Google Scholar]
- 37.Schneider H, Hlophe H, Van Rensburg D. Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects. Health Policy Plan. 2008;23:179–187. doi: 10.1093/heapol/czn006. [DOI] [PubMed] [Google Scholar]
- 38.Heunis C, Engelbrecht M, Kigozi G, Jacobs N, Janse van Rensburg A, Janse van Rensburg-Bonthuyzen E. HIV counselling and testing (HCT) of TB patients in Matjhabeng, Maluti-a-Phofung, Setsoto and Dihlabeng sub-districts: baseline surveys among nurses, community health workers and patients. Bloemfontein: Centre for Health Systems Research & Development; 2012. [Google Scholar]
- 39.Noble M, Babita M, Barnes H, Dibben C, Magasella W, Noble S, et al. The provincial indices of multiple deprivation for South Africa, 2001. Oxford: University of Oxford; 2006. [Google Scholar]
- 40.Statistics South Africa . Use of health facilities and levels of selected health conditions in South Africa: findings from the general household survey, 2011. Pretoria: Statistics South Africa; 2011. [Google Scholar]
- 41.World Health Organization . Implementing the end TB strategy: the essentials. Geneva: WHO; 2015. [Google Scholar]
- 42.Department of Health, Republic of South Africa. Pocket guide for provider counselling and testing (PICT). Pretoria: DoH; n.d.
- 43.Getahun B, Wubie M, Dejenu G, Manyazewal T. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis. Infect Dis Poverty. 2016;5(1):93. doi: 10.1186/s40249-016-0187-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Department of Health, Republic of South Africa . National Tuberculosis Management Guidelines 2014. Pretoria: Department of Health; 2014. [Google Scholar]
- 45.Yellappa V, Lefèvre P, Battaglioli T, Narayanan D, Van der Stuyft P. Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India. BMC Health Serv Res. 2016;16:283. doi: 10.1186/s12913-016-1545-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Austin-Evelyn K, Rabkin M, Macheka T, Mutiti A, Mwansa-Kambafwile J, Dlamini T, et al. Community health worker perspectives on a new primary health care initiative in the Eastern Cape of South Africa. PLoS One. 2017;12(3):e0173863. doi: 10.1371/journal.pone.0173863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Statistics South Africa. Dihlabeng. http://www.statssa.gov.za/?page_id=993&id=dihlabeng-municipality. 2011. Accessed 31 Jan 2017.
- 48.Statistics South Africa. Maluti-a-Phofung. http://www.statssa.gov.za/?page_id=993&id=maluti-a-phofung-municipality. 2011. Accessed 19 Dec 2017.
- 49.Statistics South Africa. Matjhabeng. http://www.statssa.gov.za/?page_id=993&id=matjhabeng-municipality. 2011. Accessed 19 Dec 2017.
- 50.Statistics South Africa. Setsoto. http://www.statssa.gov.za/?page_id=993&id=setsoto-municipality. 2011. Accessed 19 Dec 2017.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The dataset analysed during the current study is available from the corresponding author on reasonable request.